Press Releases

Let's spread the word about Immunotherapy! Click to share this page with your community.
July 11, 2018

Ludwig and CRI Launch Clinical Trial Combining Virotherapy and Immunotherapy to Treat Colorectal and Ovarian Cancers

Ludwig Cancer Research and the Cancer Research Institute (CRI) announce the initiation of a clinical trial to evaluate the combination of ONCOS-102, an experimental anti-tumor virotherapy, with the checkpoint blockade antibody IMFINZI® (durvalumab) for advanced ovarian and colorectal cancers. 

May 25, 2018

Global Landscape of Cancer Cell Therapy

A comprehensive, neutral analysis of the global cancer cell therapy landscape; 753 cancer cell therapies in the global development pipeline, with 375 in clinical studies

May 16, 2018

Sixth Annual Cancer Immunotherapy Month

30 days of education and awareness programming for patients, caregivers, and the public about cancer immunotherapy and clinical trials

April 05, 2018

Comprehensive Immunotherapy Tool to Analyze Interactions Between Tumors and Immune Microenvironment

Cancer Research Institute iAtlas Poised to Improve Patient Outcomes by Providing Researchers Greater Access to Genomics Data

January 08, 2018

CRI and CCTG Announce Strategic Collaboration

Two leading non-profits combine efforts to accelerate cancer immunotherapy for patients globally

*Immunotherapy results may vary from patient to patient.